bioLytical Laboratories clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   Performance, Usability, and Contrived Result Interpretation of…Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test

   Primary completion pushed from Sep 1, 2026 to Dec 1, 2026

   bioLytical Laboratories·Not applicable· NCT07563309· Registry history of NCT07563309 on ClinicalTrials.gov (opens the registry)

   Updated Oct 2, 2026

2. Minor

   Performance, Usability, and Contrived Result Interpretation of…Performance, Usability, and Contrived Result Interpretation of iStatis Gonorrhea Antigen Test

   Primary completion pushed from Sep 1, 2026 to Dec 1, 2026

   bioLytical Laboratories·Not applicable· NCT07569900· Registry history of NCT07569900 on ClinicalTrials.gov (opens the registry)

   Updated Sep 30, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.